Feasibility of Telaprevir-Based Triple Therapy in Liver Transplant Patients with Hepatitis C Virus: SVR 24 Results

由 Werner, Christoph R., Egetemeyr, Daniel P., Lauer, Ulrich M., Nadalin, Silvio, Königsrainer, Alfred, Malek, Nisar P., Berg, Christoph P.
出版 2013

First-generation protease inhibitor-triple therapy: SVR 24, safety, and predictors of response in a large single center cohort

由 Werner, Christoph R, Franz, Carolin, Egetemeyr, Daniel P, Beck, Robert, Malek, Nisar P, Lauer, Ulrich M, Berg, Christoph P
發表在 Virol J (2015)

Second-generation direct-acting-antiviral hepatitis C virus treatment: Efficacy, safety, and predictors of SVR12

由 Werner, Christoph R, Schwarz, Julia M, Egetemeyr, Daniel P, Beck, Robert, Malek, Nisar P, Lauer, Ulrich M, Berg, Christoph P
發表在 World J Gastroenterol (2016)